investors.edgewisetx.comEdgewise Therapeutics, Inc. - Investor
investors.edgewisetx.com Profile
Investors.edgewisetx.com is a subdomain of Edgewisetx.com, which was created on 2017-05-24,making it 7 years ago.
Discover investors.edgewisetx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.edgewisetx.com Information
| HomePage size: 112.254 KB |
| Page Load Time: 0.140328 Seconds |
| Website IP Address: 162.159.129.11 |
investors.edgewisetx.com Similar Website
| Aratana Therapeutics Investor Overview |
| Synopsys, Inc. | Investor Relations & Investor Resources |
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| Investor Relations :: Checkpoint Therapeutics, Inc. (CKPT) |
| Investor Relations | TG Therapeutics, Inc. |
| Revance Therapeutics, Inc. - Investor Relations |
| Investor Overview | Mateon Therapeutics |
| Coya Therapeutics - Investor Relations |
| Investor Relations :: BioXcel Therapeutics, Inc. (BTAI) |
| United Therapeutics Investor Relations |
| Mirati Therapeutics Inc. - Investor & Media Relations |
| Cyteir Therapeutics - Investor |
| Halozyme Therapeutics, Inc. - Investor |
investors.edgewisetx.com PopUrls
| Edgewise Therapeutics, Inc. - Investor Relations https://investors.edgewisetx.com/overview/default.aspx |
| Stock Info https://investors.edgewisetx.com/stock-info/default.aspx |
| Edgewise Therapeutics, Inc. - News https://investors.edgewisetx.com/news/ |
| Financials - SEC Filings https://investors.edgewisetx.com/financials/sec-filings/default.aspx |
| Governance - Executive Management https://investors.edgewisetx.com/governance/executive-management/default.aspx |
| Edgewise Therapeutics, Inc. - Financials - Quarterly Results https://investors.edgewisetx.com/financials/quarterly-results/default.aspx |
| Analyst Coverage https://investors.edgewisetx.com/Analyst-Coverage/default.aspx |
| Edgewise Therapeutics, Inc. - Resources - Investor Contacts https://investors.edgewisetx.com/resources/investor-contacts/default.aspx |
| Edgewise Therapeutics, Inc. - Resources - Investor FAQs https://investors.edgewisetx.com/resources/investor-faqs/default.aspx |
| Edgewise Therapeutics, Inc. - Investor Relations https://investors.edgewisetx.com/overview/ |
| Edgewise Therapeutics, Inc. - News https://investors.edgewisetx.com/news/default.aspx |
| Edgewise Therapeutics, Inc. - Events & Presentations https://investors.edgewisetx.com/events-and-presentations/default.aspx |
| Edgewise Therapeutics, Inc. - Analyst Coverage https://investors.edgewisetx.com/analyst-coverage/default.aspx |
investors.edgewisetx.com Httpheader
| Date: Thu, 16 May 2024 00:43:43 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 884755cd7ce32b5f-LAX |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: |
investors.edgewisetx.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.cloudfront.net *.cloudflareinsights.com *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="oQuvSwDsWTgCYKd6fOucYV41XQj49dhrcdEY4YvRx6s" name="google-site-verification"/ |
| content="7PZC33CdqIbp0gWcZwGxHNtjuQpXcOTuQqGcQxSCY3k" name="google-site-verification"/ |
| content="jHblsdRXyz6utoPE2TiLGwbeL4Cj4_UHr_jhcWJVFBQ" |
investors.edgewisetx.com Html To Plain Text
RelationsOverview Corporate Profile News Events & Presentations Analyst Coverage Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Financials Quarterly Results SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Investor FAQs Investor Email Alerts Investor Contacts Search query Search query Overview Corporate Profile News Events & Presentations Analyst Coverage Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Financials Quarterly Results SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Investor FAQs Investor Email Alerts Investor Contacts Investor Relations Corporate Profile Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by our holistic drug discovery approach to targeting the muscle as an organ, we have combined our foundational expertise in muscle biology and small molecule engineering to build our proprietary, muscle focused drug discovery platform. Our platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. Latest News View all Featured Presentations View All Latest Events View All More results Quick Links SEC Filings Investor FAQs Information Request Form IR Contact [email protected] Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. Edgewise Therapeutics, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Edgewise Therapeutics, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Unsubscribe Email Alert Sign Up Confirmation Contact Us 1715 38th St, Boulder, CO 80301 720.262.7002 [email protected] www.edgewisetx.com Quick Links Company Research & Development News Powered By Q4 Inc. 5.122.0.3 (opens in new window) Follow us Contact Us Privacy Policy Terms of Use Cookie Preferences © 2024 Copyright. Edgewise Therapeutics. All...
investors.edgewisetx.com Whois
Domain Name: EDGEWISETX.COM Registry Domain ID: 2127375486_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-03T09:22:14Z Creation Date: 2017-05-24T01:41:36Z Registry Expiry Date: 2024-05-24T01:41:36Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS77.DOMAINCONTROL.COM Name Server: NS78.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-18T05:10:27Z <<<